Xylem (XYL) is moving higher as investors reprice the stock around a newly authorized $1.5 billion share repurchase program that signals confidence in cash generation and a shift toward shareholder returns. The authorization has no stated expiration date, giving Xylem flexibility to buy shares on weakness and potentially provide a technical bid under the stock.

The repurchase authorization was announced on February 25, 2026 and is described as a $1.5 billion program. Company materials and third-party recaps peg the authorization at roughly 4.8% of shares outstanding, a meaningful size for a large-cap industrial and an immediate catalyst for EPS accretion expectations as repurchases ramp. The company framed the authorization as aligned with its strategy and ability to generate sustainable cash flow.

Traders will watch for signals that repurchases are actively being executed (pace, timing, and any incremental authorization), as well as upcoming quarterly results and commentary on demand trends in municipal water infrastructure. Any updates to 2026 outlook (revenue growth, margin expansion, and EPS expectations) could amplify or reverse the post-buyback enthusiasm if fundamentals don’t support the capital-return narrative.